Targeted drug could benefit young patients with invasive sarcoma
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Dec-2025 03:11 ET (22-Dec-2025 08:11 GMT/UTC)
A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at the University of Utah, has identified a targeted drug that could effectively treat an aggressive soft tissue cancer that occurs most often in pediatric and young adult patients. New findings—published in Nature Communications—suggest that blocking a specific genetic pathway could reverse a series of tumor-driving cellular interactions to restore DNA function and benefit patients with synovial sarcoma.
A new study published in AJPM Focus found that the risk of child firearm injuries was 45 percent higher during the 2-6 pm afterschool period on school days, compared to non-school days, among students at public schools in New York City. This risk nearly tripled in the immediate period at the end of the school day, typically about 2 pm. A second study, published in Prevention Science, examined the benefits of summer youth employment programs and found that these programs not only reduce youth involvement in crime and violence, but also improve youth educational outcomes, social connections, and community engagement.
A new study seeks to prevent nonmelanoma skin cancers, reducing the need for invasive treatments such as surgery or chemotherapy.